McKinsey to fix opioid probe for $573 mn

McKinsey & Co, the consulting firm, has agreed to pay $573 million to resolve investigations by most U.S. States over its alleged role in ‘turbocharging’ sales of opioids such as OxyContin, fuelling a nationwide epidemic.

Most money from the settlement with 47 States, the District of Columbia and five territories will go toward opioid treatment and prevention.

McKinsey did not admit liability or wrongdoing, and said it had also settled with two additional States, boosting its payout to nearly $600 million.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.


A one-stop-shop for seeing the latest updates, and managing your preferences.


We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *